Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2021 Results Conference Call November 4, 2021 8:00 AM ET
Company Participants
Ian Karp - SVP, IR and Corporate Communications
Dr. John Leonard - CEO
Dr. David Lebwohl - Chief Medical Officer
Dr. Laura Sepp-Lorenzino - Chief Scientific Officer
Glenn Goddard - CFO
Conference Call Participants
Maury Raycroft - Jefferies
Joon Lee - Truist Securities
Rick Bienkowski - SVB Leerink
Xiaobin Gao - Barclays
Luca Issi - RBC
Liisa Bayko - Evercore ISI
Yanan Zhu - Wells Fargo
Dae Gon Ha - Stifel
Timur Ivannikov - Raymond James
Jay Olson - Oppenheimer
Silvan Tuerkcan - JMP Securities
Operator
Good morning and welcome to the Intellia Therapeutics Third Quarter 2021 Financial Results Conference Call. My name is Drew and I will be your conference operator today.
Following formal remarks, we will open the call up for a question-and-answer session. This conference is being recorded at the Company's request and will be available on the Company's website following the end of the call. As a reminder, all participants are currently in listen-only mode. [Operator Instructions]
I will now turn the conference over to Ian Karp, Senior Vice President of Investor Relations and Corporate Communications at Intellia. Please proceed.
Ian Karp
Thank you, and good morning, everyone. Welcome to Intellia Therapeutics third quarter 2021 earnings call.
Earlier this morning, Intellia issued a press release outlining the Company's progress this quarter, as well as topics for discussion on today's call. This release can be found on the Investors & Media section of Intellia's website at intelliatx.com. This call is being broadcast live and a replay will be archived on the Company's website.
At this time, I would like to take a minute to remind listeners that during the call, Intellia management may make certain forward-looking statements and ask that you refer
- Read more current NTLA analysis and news
- View all earnings call transcripts